Sartorius Aktiengesellschaft/€SRT
05:30
09:10
12:45
16:25
20:00
1D1W1MYTD1Y5YMAX
About Sartorius Aktiengesellschaft
Sartorius Aktiengesellschaft is a German company engaged in the development, manufacturing, and distribution of laboratory equipment and bioprocess solutions. The company's core business is centered around two main segments: Bioprocess Solutions, which includes products for the production of biopharmaceuticals, such as filters, bags, and bioreactors, and Lab Products & Services, offering laboratory instruments like balances and pipettes for various research applications. Founded in 1870, Sartorius is headquartered in Göttingen, Germany, and maintains a global presence with operations in Europe, Asia, and the Americas. Its strategic positioning is reinforced by a strong focus on innovation and comprehensive product offerings catering to the biopharmaceutical industry. Competitive strengths include robust R&D capabilities and a well-integrated supply chain that supports rapid adaptation to industry demands. Sources: Sartorius Corporate Website, Annual Reports.
Ticker
€SRT
Sector
Primary listing
XETRA
Employees
13,685
Headquarters
Website
SRT Metrics
BasicAdvanced
€12B
-
-
1.24
€0.73
0.46%
Price and volume
Market cap
€12B
Beta
1.24
52-week high
€195.00
52-week low
€145.40
Average daily volume
1.6K
Dividend rate
€0.73
Financial strength
Current ratio
1.394
Quick ratio
0.77
Long term debt to equity
107.751
Total debt to equity
122.695
Dividend payout ratio (TTM)
48.70%
Interest coverage (TTM)
2.58%
Profitability
EBITDA (TTM)
781
Gross margin (TTM)
45.76%
Net profit margin (TTM)
3.00%
Operating margin (TTM)
13.69%
Effective tax rate (TTM)
26.64%
Revenue per employee (TTM)
€250,000
Management effectiveness
Return on assets (TTM)
2.97%
Return on equity (TTM)
4.46%
Valuation
Dividend yield (TTM)
0.46%
Forward dividend yield
0.46%
Growth
Revenue change (TTM)
3.80%
3-year revenue growth (CAGR)
-3.68%
10-year revenue growth (CAGR)
13.20%
3-year dividend per share growth (CAGR)
-16.26%
10-year dividend per share growth (CAGR)
10.82%
Bulls say / Bears say
Sartorius posted underlying EBITDA of €263 million in Q1 2025, up 12.2%, with its EBITDA margin up to 29.8%, showing strong operating leverage and profitability improvements. (Reuters)
The Group’s Q1 2025 order intake stayed solid, with a book-to-bill ratio well above 1, pointing to sustained demand across its business segments. (Reuters)
In Q4 2024, Bioprocess Solutions orders soared 23.1% to €856.7 million, topping J.P. Morgan estimates by 22%, highlighting strong end-market demand. (Reuters)
Lab Products & Services sales fell 4.8% in constant currencies in H1 2025, and underlying EBITDA margin narrowed to 22.3% from 23.6% a year earlier, signaling ongoing weakness in the lab division. (FT)
Equipment and systems sales in the Bioprocess Solutions segment stayed soft as customers remained reluctant to invest in capital-intensive solutions, offsetting consumables growth. (FT)
Despite beating preliminary results, Sartorius projects 2025 growth below its long-term average, reflecting a cautious outlook as the company manages a recovery in the still-volatile life sciences market. (Reuters)
Data summarised monthly by Lightyear AI. Last updated on 3 Sept 2025.
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Sartorius Aktiengesellschaft stock?
Sartorius Aktiengesellschaft (SRT) has a market cap of €12B as of September 15, 2025.
What is the P/E ratio for Sartorius Aktiengesellschaft stock?
The price to earnings (P/E) ratio for Sartorius Aktiengesellschaft (SRT) stock is 0 as of September 15, 2025.
Does Sartorius Aktiengesellschaft stock pay dividends?
Yes, the Sartorius Aktiengesellschaft (SRT) stock pays dividends to shareholders. As of September 15, 2025, the dividend rate is €0.73 and the yield is 0.46%. Sartorius Aktiengesellschaft has a payout ratio of 48.7% on a trailing twelve-month basis.
When is the next Sartorius Aktiengesellschaft dividend payment date?
The next Sartorius Aktiengesellschaft (SRT) dividend payment date is unconfirmed.
What is the beta indicator for Sartorius Aktiengesellschaft?
Sartorius Aktiengesellschaft (SRT) has a beta rating of 1.24. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.